TruthArchive.ai - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary

The speaker, a physician and psychiatrist, states that medicine faces the difficulty that most disease is preventable, but the medical field profits from curing or ameliorating disease with medications and procedures. The speaker claims that the medical field does not profit from preventing disease by encouraging people to socialize or exercise.

Video Saved From X

reSee.it Video Transcript AI Summary

Sugar fuels cancer, as it operates as a fermentation system reliant on it. Despite Otto Warburg receiving a Nobel Prize for his findings, the focus shifted back to chemotherapy and radiation, which do not cure cancer. This approach leads to disease management rather than finding a cure. The financial incentive lies in treating chronic conditions rather than curing them, as the profit comes from those who require ongoing treatment rather than from healthy individuals or those who have passed away.

Video Saved From X

reSee.it Video Transcript AI Summary

Major drug companies are controlled by a group of individuals connected to Chase Manhattan Bank and Exxon. Their goal is to control all aspects of biology, from birth to death, including hormones, glands, and genes. John D. Rockefeller took over the medical industry in 1910, establishing a monopoly that still exists today. This allopathic system of medicine controls hospitals, physicians, and medications. As a result, healthcare costs in the US have skyrocketed, making it unaffordable for most citizens. Cancer treatment is particularly expensive, with an average cost of $120,000. Despite the high costs, doctors often offer limited options and focus on extracting money from patients. These monopolies are interconnected and controlled by a small group of elitists.

Video Saved From X

reSee.it Video Transcript AI Summary

Pharma whistleblower Brigham Bueller exposes the pharmaceutical industry's broken incentives and aims to empower patients. According to Bueller, the current system is failing to prevent chronic diseases because the industry profits from them. He asserts that expecting insurance or pharmaceutical companies to prioritize the well-being of individuals is a mistake. Bueller emphasizes that this issue transcends politics and is a matter of humanity, expressing hope that the system can be fixed.

Video Saved From X

reSee.it Video Transcript AI Summary

There are 250,000 drugs in the PDR, but none are designed to cure anything except maybe antibiotics for strep throat. Pharmaceutical companies focus on making money from insurance policies rather than creating cures. Laws do not require them to produce drugs that cure, despite their ability to do so.

Video Saved From X

reSee.it Video Transcript AI Summary

Major drug companies are controlled by a group that includes officials from Chase Manhattan Bank and Exxon. Their goal is to control all aspects of biology, from birth to death, including hormones, glands, and genes. John D. Rockefeller took over the medical industry in 1910, creating a monopoly that still exists today. The cost of healthcare has skyrocketed, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with an average cost of $120,000. Doctors often offer treatments that are costly and painful, providing little hope for survival. These monopolies are all connected and controlled by the same group of elitists.

Video Saved From X

reSee.it Video Transcript AI Summary

It used to be that pharmaceutical companies were working with the doctors. Now unfortunately, companies are captured by the price of the stock. Know, venture capitalist owned pharmaceutical companies. They owned the CR or the clinical research organizations. They owned the site. They owned the institutional review board. They owned the advertising, the marketing. They influenced through the media. And so unfortunately, there's a big it's a it's a loaded question, but it's a big market. And what we saw this pandemic was the price of the stock mattered more than the price of a life.

Video Saved From X

reSee.it Video Transcript AI Summary

The healthcare industry profits from our sickness, depression, and infertility, making chronic disease a lucrative business. Pharma and food industries are interconnected in fueling this cycle. We are encouraged to rely on pills, fear the system, and keep consuming.

Video Saved From X

reSee.it Video Transcript AI Summary

Our initial response to COVID incentivized hospitals to prioritize profit over patient care, leading to questionable treatment decisions. Medical boards, influenced by financial gain, hindered effective protocols like those of Doctor Bartlett. This highlights the need to hold medical boards accountable for prioritizing money over patient well-being.

Video Saved From X

reSee.it Video Transcript AI Summary

Friendship is based on shared values, and the group shares a lifelong vision to make the country healthy with evidence-based, replicable science. This will challenge the current system, which is destroying our health due to misaligned economic incentives and public health. The speaker met with heads of pharmaceutical companies, stating the desire to live in a place where companies profit by making people healthy, rather than the current alignment against each other. The healthcare system has perverse incentives that force people to do the wrong thing. The country has become a sick care system instead of a health care system, and the people in the group will change that.

Video Saved From X

reSee.it Video Transcript AI Summary

Various vaccines are being linked to multiple industries. The motive behind this is believed to be financial gain. The companies selling vaccines are making $60 billion annually, while the ones selling remedies for vaccine-related injuries are making a staggering $500 billion. This business model involves selling medications for diabetes, ADHD, asthma, seizures, and more. The strategy seems to be making people sick and then providing them with lifelong treatments.

Video Saved From X

reSee.it Video Transcript AI Summary

Major drug companies are controlled by a group of individuals from Chase Manhattan Bank, Exxon, and other companies. Their goal is to control all aspects of biology, from birth to death, including hormones, glands, and genes. This is part of their larger plan for social control and eugenics. John D. Rockefeller took over the medical industry in 1910, creating a monopoly that still exists today. The cost of healthcare has skyrocketed, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with little promise of success. These monopolies are all connected and controlled by the same group of elitists.

Video Saved From X

reSee.it Video Transcript AI Summary

Hospitals need to grow economically, but a problem arises when healing methods don't involve pills or surgery. If patients heal without incurring charges, the hospital and doctor face financial difficulties. Discovering a way to heal people that cannot be charged for equates to working oneself out of a job.

Video Saved From X

reSee.it Video Transcript AI Summary

Goldman Sachs questioned if curing patients is a sustainable business model, concluding it is not because a cured patient is a lost customer. Another leaked document revealed Goldman Sachs criticizing Gilead for creating a cure for hepatitis C in 2013. Goldman Sachs allegedly sent a letter to Gilead, stating that they "messed up" by pursuing a cure instead of focusing on treatments. The claim is that Goldman Sachs advised Gilead to prioritize medications that patients need long-term to manage their disease, ensuring continuous drug sales.

Video Saved From X

reSee.it Video Transcript AI Summary

A leaked Goldman Sachs meeting revealed the question, "Is curing patients a sustainable business model?" The conclusion was no, because a cured patient is a lost customer. Another leaked document showed Goldman Sachs criticizing Gilead, a company that created a cure for hepatitis C in 2013. Goldman Sachs allegedly sent Gilead an angry letter, stating that they "messed up" by pursuing a cure instead of a treatment. The claim is that the preferred business model is to provide medication that patients can use to live with their disease, allowing the company to sell the drug for the rest of their lives.

Video Saved From X

reSee.it Video Transcript AI Summary

A health insurance CEO was recently murdered, sparking surprising support for the act among some younger people, reflecting deep-seated anger towards insurance companies. The discussion highlights how these companies profit from chronic diseases by delaying care and prioritizing profit over patient health. The insurance model has shifted from personal care to a profit-driven system, leading to inadequate patient interactions and a focus on prescription drugs rather than preventative measures. The conversation also touches on the role of pharmacy benefit managers (PBMs) as profit centers for insurers, contributing to rising healthcare costs. Advocates argue for a shift towards proactive, preventative care, emphasizing the need for transparency and accountability in the healthcare system to address chronic diseases effectively.

Video Saved From X

reSee.it Video Transcript AI Summary

Curing patients of diseases is seen as detrimental to the business model, according to a major investment firm. The potential for one-shot cures through gene therapy is attractive, but it poses a challenge to recurring revenue compared to chronic therapies. While curing people would benefit society and patients, it would negatively impact cash flow. The firm openly admits that their concern lies in financial gain rather than the well-being of individuals. This example highlights the flaws in our market economy and the exploitation of others for profit. It calls for a revolution of the mind to prioritize the eradication of diseases over monetary interests.

Video Saved From X

reSee.it Video Transcript AI Summary

Most physicians and clinicians avoid getting involved in the issue of profit-driven healthcare. The real problem lies in the collusion between academic institutions, doctors, medical journals, and industry for financial gain. These corporations, as legal entities, often exhibit psychopathic traits, prioritizing profit over the well-being of patients. Many top drug companies have been fined billions for illegal marketing, hiding harm data, and manipulating results. However, these fines are often outweighed by the profits they make from selling the drugs. While the pharmaceutical industry has contributed life-saving treatments, the net effect of their practices is negative, with a significant amount of wasted resources and harmful drugs approved.

Video Saved From X

reSee.it Video Transcript AI Summary

Reports from China indicate scientists may have found a diabetes cure, which is unwelcome news for the American pharmaceutical industry. Chinese patients receiving experimental stem cell therapy have stopped needing insulin after about eleven weeks. This poses a threat to companies like Eli Lilly, who profit greatly from the insulin market. The rising insulin prices have sparked controversy, especially considering insulin's inventor, Frederick Banting, sold the patent for $1, believing it should be accessible to everyone. A diabetes cure would reduce the demand for insulin, impacting pharmaceutical companies' profits. This reveals a contradiction within the American for-profit healthcare system, where cures are disincentivized if they eliminate the need for repeat customers, challenging the notion that capitalism always promotes innovation.

Video Saved From X

reSee.it Video Transcript AI Summary

The pandemic created 40 new big pharma billionaires. Companies like Moderna and Pfizer profited $1,000 per second from the COVID vaccine. Over 2/3 of congress received campaign funding from pharmaceutical companies in 2020. Pfizer's chairman mentioned developing the vaccine for humanity, not money, but the company made $100 billion in profit. The public funded the vaccine development, but companies took the profits. The system benefits from crises like medical emergencies, war, and energy crises, leading to perpetual crises for ordinary people's interests. Industries profit from these crises, like the COVID testing industry.

Video Saved From X

reSee.it Video Transcript AI Summary

A health insurance CEO was murdered, sparking a surprising reaction among younger people, with 41% expressing support. This reflects a deep-seated anger towards insurance companies, which many believe contribute to America's chronic disease crisis by prioritizing profits over patient care. The discussion highlights the profit-driven nature of health insurance, particularly through pharmacy benefit managers (PBMs), which inflate drug prices and create barriers to necessary care. The system favors medication over preventative measures, leading to widespread chronic illness. Advocates emphasize the need for a shift towards proactive healthcare that focuses on prevention and transparency, rather than a reliance on prescription drugs. The conversation underscores the urgent need for reform in the healthcare system to prioritize patient well-being over corporate profits.

Video Saved From X

reSee.it Video Transcript AI Summary

Major drug companies are controlled by a group that includes representatives from Chase Manhattan Bank and Exxon. Their goal is to control all aspects of biology, from birth to death, including hormones, glands, and genes. John D. Rockefeller took over the medical industry in 1910, creating a monopoly that still exists today. This has led to skyrocketing healthcare costs, especially for cancer treatment, which can cost around $120,000. Despite the high costs, doctors often offer little hope for a cure. These monopolies are all connected and controlled by a small group of elitists known as the world order people.

Video Saved From X

reSee.it Video Transcript AI Summary

Major drug companies worldwide are controlled by a group of individuals connected to Chase Manhattan Bank and Exxon. Their aim is to control all aspects of biology, from birth to death, including hormones, glands, and genes. This is part of their broader goal of social control and eugenics. Since 1910, John D. Rockefeller took over the medical industry in the US, leading to the current allopathic system of medicine. The cost of healthcare has skyrocketed, making it unaffordable for most Americans. Cancer treatment, for example, costs around $120,000, with little promise of a cure. These monopolies are interconnected, with the same group of elitists behind them.

Modern Wisdom

How America’s Healthcare System Keeps You Dependent - Calley Means

Guests: Calley Means

reSee.it Podcast Summary

Modern healthcare is fundamentally flawed due to economic incentives that profit from prolonged illness rather than promoting health. Insurance companies, under the Affordable Care Act, are incentivized to raise premiums, which leads to higher costs and more sickness. Pharmaceutical companies focus on chronic disease management, as 95% of their sales come from treatments for conditions like heart disease and diabetes, which require ongoing medication rather than cures. This creates a cycle where sick patients are more profitable. Childhood obesity and chronic diseases are rising, with 50% of teens overweight or obese. The pharmaceutical industry profits from this trend, as a healthy child is not a profitable patient. The healthcare system is structured to prioritize interventions and treatments over preventative measures. Hospitals, as the largest employers, are incentivized to fill beds and perform procedures, often leading to unnecessary surgeries and prescriptions. The healthcare system's focus on treating symptoms rather than root causes is evident in the rise of medications like statins and antidepressants, which are prescribed without addressing lifestyle factors. The American Academy of Pediatrics has recently recommended aggressive interventions for overweight children, influenced by pharmaceutical funding. Environmental factors, including diet and toxins, contribute significantly to chronic health issues. The prevalence of ultra-processed foods, heavily subsidized and marketed, exacerbates these problems. The U.S. food system is designed to promote unhealthy eating habits, with government programs like SNAP allowing the purchase of sugary drinks. The conversation around health must shift from treating diseases to promoting overall wellness. This includes recognizing the interconnectedness of various health conditions and addressing metabolic dysfunction as a root cause. The healthcare system needs to be reoriented to prioritize preventative care and holistic health solutions. The current trajectory of healthcare spending is unsustainable, with chronic diseases projected to bankrupt the system. There is a need for bipartisan action to reform healthcare policies, focusing on clean food and water, and addressing the systemic issues that lead to poor health outcomes. The conversation must include a reevaluation of how healthcare is funded and the role of pharmaceutical companies in shaping health guidelines.

a16z Podcast

Big Ideas in 2024: Democratizing “Miracle Drugs” with Julie Yoo

Guests: Julie Yoo

reSee.it Podcast Summary

In 2024, a16z partners highlight the need to democratize miracle drugs, particularly GLP-1s and cell and gene therapies, which have shown significant benefits but face challenges in healthcare accessibility. GLP-1s, initially for type 2 diabetes, also aid weight loss, impacting over 42% of Americans. Despite 3.6 million prescriptions in 2022, insurance coverage remains limited, with only about 25% of employer-sponsored plans covering these drugs. The high costs, often exceeding $1,000 monthly, complicate reimbursement and access. Cell and gene therapies, while promising cures for genetic diseases, can cost millions and require complex administration, further straining the healthcare system. The current insurance model does not incentivize upfront payments for long-term benefits, necessitating innovative financing solutions. Entrepreneurs are developing systems to streamline manufacturing, logistics, and data collection, but a holistic approach involving payers, providers, and patients is essential. Policy changes from entities like the FDA and CMS are expected to guide the industry in addressing these challenges effectively.